ArticleRSC advances2025
Ratiometric near-infrared biosensors based on self-assembled nanoparticles and target-triggered signal amplification for sensitive detection of miRNAs.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The abnormal expression of microRNA-21 (miRNA-21) is highly correlated with acute myocardial infarction and can serve as a biomarker for its early diagnosis. In this study, a ratiometric fluorescent probe based on target-triggered signal amplification using upconversion nanoparticles (UCNPs) as energy donors and gold nanoparticles (AuNPs) as energy acceptors was fabricated for the detection of miRNA-21. First, hairpin DNA (H1) with sulfhydryl and amino groups at both terminations is connected to AuNPs and UCNPs through Au-S bonds and amide bonds, leading to the quenching of upconversion luminescence (UCL). The target miRNA-21 can trigger H1 and obtain a miRNA/H1 duplex structure, leading to AuNPs being far from the UCNPs and recovering the UCL. The opened H1 hairpin exposes fragments that can recognize another hairpin DNA (H2) labelled with Cy5, resulting in the target miRNA-21 being replaced by H2 and triggering catalytic hairpin assembly (CHA) signal magnification. The stationary fluorescence of Cy5 and the changing UCL of the UCNPs construct a ratiometric biosensor, which was used to detect miRNA-21, with a low detection limit (LOD) of 0.28 pM. Additionally, this biosensor can determine miRNA-21 in serum samples, with recoveries ranging from 94.3-102.7%, suggesting that the proposed method shows broad prospects in the sensitive and accurate detection of clinical sample biomarkers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.